Free Trial

Acelyrin (SLRN) News Today

Acelyrin logo
$5.68
-0.22 (-3.73%)
(As of 10/31/2024 ET)
Brokerages Set Acelyrin, Inc. (NASDAQ:SLRN) PT at $11.17
Acelyrin, Inc. stock logo
Acelyrin, Inc. (NASDAQ:SLRN) Given Consensus Rating of "Moderate Buy" by Analysts
Shares of Acelyrin, Inc. (NASDAQ:SLRN - Get Free Report) have received an average recommendation of "Moderate Buy" from the six brokerages that are presently covering the company, MarketBeat.com reports. Three analysts have rated the stock with a hold rating and three have given a buy rating to th
Acelyrin, Inc. stock logo
Acelyrin, Inc. (NASDAQ:SLRN) Short Interest Down 19.2% in October
Acelyrin, Inc. (NASDAQ:SLRN - Get Free Report) was the target of a significant decrease in short interest during the month of October. As of October 15th, there was short interest totalling 5,160,000 shares, a decrease of 19.2% from the September 30th total of 6,390,000 shares. Based on an average trading volume of 1,010,000 shares, the days-to-cover ratio is presently 5.1 days. Approximately 8.0% of the shares of the stock are sold short.
Acelyrin, Inc. stock logo
Acelyrin (NASDAQ:SLRN) Stock Price Down 6.9% - Here's What Happened
Acelyrin (NASDAQ:SLRN) Stock Price Down 6.9% - What's Next?
Acelyrin, Inc. stock logo
Acelyrin (NASDAQ:SLRN) Trading Up 4.8% on Analyst Upgrade
Acelyrin (NASDAQ:SLRN) Stock Price Up 4.8% After Analyst Upgrade
Acelyrin, Inc. stock logo
Wells Fargo & Company Boosts Acelyrin (NASDAQ:SLRN) Price Target to $15.00
Wells Fargo & Company lifted their target price on Acelyrin from $13.00 to $15.00 and gave the company an "overweight" rating in a research note on Wednesday.
Acelyrin, Inc. stock logo
Acelyrin (NASDAQ:SLRN) Stock Price Down 2.4% - What's Next?
Acelyrin (NASDAQ:SLRN) Stock Price Down 2.4% - Time to Sell?
Acelyrin, Inc. stock logo
Acelyrin (NASDAQ:SLRN) Shares Up 5.9% - Time to Buy?
Acelyrin (NASDAQ:SLRN) Trading 5.9% Higher - Here's What Happened
Acelyrin, Inc. stock logo
Acelyrin, Inc. (NASDAQ:SLRN) Shares Sold by Point72 Asset Management L.P.
Point72 Asset Management L.P. lessened its stake in Acelyrin, Inc. (NASDAQ:SLRN - Free Report) by 83.2% in the second quarter, according to its most recent filing with the Securities & Exchange Commission. The institutional investor owned 37,542 shares of the company's stock after selling 185,
Acelyrin, Inc. stock logo
Millennium Management LLC Boosts Stock Holdings in Acelyrin, Inc. (NASDAQ:SLRN)
Millennium Management LLC grew its stake in shares of Acelyrin, Inc. (NASDAQ:SLRN - Free Report) by 15.7% in the 2nd quarter, according to its most recent filing with the Securities & Exchange Commission. The firm owned 4,642,056 shares of the company's stock after buying an additional 628,528
Acelyrin, Inc. stock logo
Renaissance Technologies LLC Raises Position in Acelyrin, Inc. (NASDAQ:SLRN)
Renaissance Technologies LLC lifted its stake in Acelyrin, Inc. (NASDAQ:SLRN - Free Report) by 218.0% in the 2nd quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The institutional investor owned 397,618 shares of the company's stock after purchasing a
Acelyrin, Inc. stock logo
160,167 Shares in Acelyrin, Inc. (NASDAQ:SLRN) Bought by Susquehanna Fundamental Investments LLC
Susquehanna Fundamental Investments LLC bought a new position in shares of Acelyrin, Inc. (NASDAQ:SLRN - Free Report) during the second quarter, according to its most recent disclosure with the Securities & Exchange Commission. The fund bought 160,167 shares of the company's stock, valued at ap
Acelyrin, Inc. stock logo
Acelyrin, Inc. (NASDAQ:SLRN) Given Average Rating of "Moderate Buy" by Analysts
Acelyrin, Inc. (NASDAQ:SLRN - Get Free Report) has received a consensus recommendation of "Moderate Buy" from the six research firms that are covering the stock, Marketbeat.com reports. Three equities research analysts have rated the stock with a hold rating and three have issued a buy rating on
Acelyrin, Inc. stock logo
Almitas Capital LLC Buys New Position in Acelyrin, Inc. (NASDAQ:SLRN)
Almitas Capital LLC bought a new stake in shares of Acelyrin, Inc. (NASDAQ:SLRN - Free Report) during the 2nd quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The fund bought 376,116 shares of the company's stock, valued at approximately
Acelyrin, Inc. stock logo
Short Interest in Acelyrin, Inc. (NASDAQ:SLRN) Drops By 15.4%
Acelyrin, Inc. (NASDAQ:SLRN - Get Free Report) saw a significant drop in short interest in the month of September. As of September 15th, there was short interest totalling 6,090,000 shares, a drop of 15.4% from the August 31st total of 7,200,000 shares. Approximately 9.5% of the shares of the company are sold short. Based on an average daily volume of 1,190,000 shares, the days-to-cover ratio is presently 5.1 days.
Acelyrin, Inc. stock logo
Acelyrin (NASDAQ:SLRN) Shares Down 5.4%
Acelyrin (NASDAQ:SLRN) Trading Down 5.4%
Acelyrin, Inc. stock logo
Acadian Asset Management LLC Makes New Investment in Acelyrin, Inc. (NASDAQ:SLRN)
Acadian Asset Management LLC bought a new position in Acelyrin, Inc. (NASDAQ:SLRN - Free Report) in the second quarter, according to its most recent Form 13F filing with the Securities & Exchange Commission. The firm bought 134,184 shares of the company's stock, valued at approximately $590,000
Acelyrin, Inc. stock logo
Los Angeles Capital Management LLC Invests $693,000 in Acelyrin, Inc. (NASDAQ:SLRN)
Los Angeles Capital Management LLC acquired a new stake in Acelyrin, Inc. (NASDAQ:SLRN - Free Report) in the second quarter, according to its most recent disclosure with the Securities and Exchange Commission (SEC). The fund acquired 157,093 shares of the company's stock, valued at approximately $6
Acelyrin, Inc. stock logo
Acelyrin, Inc. (NASDAQ:SLRN) Given Consensus Recommendation of "Moderate Buy" by Analysts
Acelyrin, Inc. (NASDAQ:SLRN - Get Free Report) has been assigned an average recommendation of "Moderate Buy" from the six brokerages that are presently covering the firm, MarketBeat reports. Three equities research analysts have rated the stock with a hold recommendation and three have issued a bu
Acelyrin, Inc. stock logo
Acelyrin (NASDAQ:SLRN) PT Lowered to $6.00 at Morgan Stanley
Morgan Stanley decreased their price objective on Acelyrin from $13.00 to $6.00 and set an "equal weight" rating on the stock in a research note on Monday.
Acelyrin Shares Slide on Layoffs, Portfolio Refocus
Piper Sandler Keeps Their Buy Rating on ACELYRIN, INC. (SLRN)
Acelyrin, Inc. stock logo
Acelyrin (NASDAQ:SLRN) Posts Earnings Results, Misses Expectations By $0.08 EPS
Acelyrin (NASDAQ:SLRN - Get Free Report) released its quarterly earnings results on Tuesday. The company reported ($0.86) earnings per share (EPS) for the quarter, missing the consensus estimate of ($0.78) by ($0.08). During the same period last year, the firm earned ($0.56) EPS.
Acelyrin, Inc. stock logo
Acelyrin, Inc. (NASDAQ:SLRN) Receives Consensus Recommendation of "Moderate Buy" from Brokerages
Acelyrin, Inc. (NASDAQ:SLRN - Get Free Report) has received a consensus rating of "Moderate Buy" from the six research firms that are covering the stock, Marketbeat Ratings reports. Three analysts have rated the stock with a hold recommendation and three have assigned a buy recommendation to the
Acelyrin, Inc. stock logo
Acelyrin (NASDAQ:SLRN) PT Lowered to $20.00 at Piper Sandler
Piper Sandler lowered their target price on shares of Acelyrin from $68.00 to $20.00 and set an "overweight" rating for the company in a research note on Wednesday.
Acelyrin, Inc. (SLRN) Q2 2024 Earnings Call Transcript
Acelyrin, Inc. stock logo
Acelyrin (SLRN) to Release Quarterly Earnings on Tuesday
Acelyrin (NASDAQ:SLRN) will be releasing earnings after the market closes on Tuesday, August 13, Zacks reports.
Acelyrin, Inc. stock logo
Jacobs Levy Equity Management Inc. Acquires Shares of 586,746 Acelyrin, Inc. (NASDAQ:SLRN)
Jacobs Levy Equity Management Inc. bought a new position in Acelyrin, Inc. (NASDAQ:SLRN - Free Report) during the 1st quarter, according to the company in its most recent filing with the Securities and Exchange Commission. The firm bought 586,746 shares of the company's stock, valued at approximate
Acelyrin, Inc. stock logo
Acelyrin (NASDAQ:SLRN) Stock Price Down 6.1%
Acelyrin (NASDAQ:SLRN) Trading Down 6.1%
Acelyrin, Inc. stock logo
Blair William & Co. IL Invests $936,000 in Acelyrin, Inc. (NASDAQ:SLRN)
Blair William & Co. IL acquired a new stake in Acelyrin, Inc. (NASDAQ:SLRN - Free Report) in the 1st quarter, according to the company in its most recent filing with the Securities and Exchange Commission (SEC). The firm acquired 138,595 shares of the company's stock, valued at approximately $936,0
Acelyrin, Inc. stock logo
Acelyrin (NASDAQ:SLRN) Trading Down 8.8%
Acelyrin (NASDAQ:SLRN) Shares Down 8.8%
Acelyrin, Inc. stock logo
Acelyrin (NASDAQ:SLRN) Sees Strong Trading Volume
Acelyrin (NASDAQ:SLRN) Sees Unusually-High Trading Volume
Acelyrin, Inc. stock logo
Acelyrin (NASDAQ:SLRN) Trading 9.9% Higher
Acelyrin (NASDAQ:SLRN) Shares Up 9.9%
Acelyrin, Inc. stock logo
Acelyrin (NASDAQ:SLRN) Upgraded to "Overweight" at Wells Fargo & Company
Wells Fargo & Company upgraded shares of Acelyrin from an "equal weight" rating to an "overweight" rating and set a $13.00 price objective for the company in a research note on Monday.
Acelyrin, Inc. stock logo
Superstring Capital Management LP Makes New Investment in Acelyrin, Inc. (NASDAQ:SLRN)
Superstring Capital Management LP bought a new position in shares of Acelyrin, Inc. (NASDAQ:SLRN - Free Report) during the 4th quarter, according to its most recent 13F filing with the SEC. The fund bought 356,924 shares of the company's stock, valued at approximately $2,663,000. Acelyrin makes up
Acelyrin, Inc. stock logo
Sectoral Asset Management Inc. Buys Shares of 325,549 Acelyrin, Inc. (NASDAQ:SLRN)
Sectoral Asset Management Inc. purchased a new stake in Acelyrin, Inc. (NASDAQ:SLRN - Free Report) in the 4th quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission. The fund purchased 325,549 shares of the company's stock, valued at approxi
Get Acelyrin News Delivered to You Automatically

Sign up to receive the latest news and ratings for SLRN and its competitors with MarketBeat's FREE daily newsletter.

Ex WH Advisor Who Predicted Biden Leaving Race Makes Startling New Prediction (Ad)

Former advisor to the CIA, the Pentagon and the White House Jim Rickards went on multiple TV news programs… A predicted Trump would win. You won’t believe what he’s predicting now.

Click here to see it because it’s a SHOCKER…

SLRN Media Mentions By Week

SLRN Media Sentiment

Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press.

SLRN
News Sentiment

1.02

0.68

Average
Medical
News Sentiment

SLRN News Coverage

We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week.

SLRN Articles
This Week

5

3

SLRN Articles
Average Week

Get Acelyrin News Delivered to You Automatically

Sign up to receive the latest news and ratings for SLRN and its competitors with MarketBeat's FREE daily newsletter.


Related Companies and Tools


This page (NASDAQ:SLRN) was last updated on 10/31/2024 by MarketBeat.com Staff
From Our Partners